Pressure BioSciences (OTCQB: PBIO), a leader in the development
and sale of high pressure-based instruments, consumables, and related services
for the global life sciences industry, today announced that analytical testing
on hemp-derived CBD oil processed via its Ultra Shear Technology(TM) (“UST”)
platform confirms its unique ability to achieve challenging criteria for
creating highly-effective “nanoemulsions” of CBD oil in water. Per the update,
testing results confirm these capabilities without CBD loss or modification
throughout the entire UST process, providing greater than 99 percent recovery.
“We asked an independent, university-affiliated laboratory to determine the
size of oil droplets achieved in UST-processed CBD oil, using a
universally-accepted sizing method called DLS,” PBIO Director of Applications Development
Dr. Vera Gross explained in the news release. “Their analytical results
revealed that the UST- processed oil drops were reduced to approximately 65 nm
in size, well into the 20-200 nm range targeted for truly effective
nanoemulsion delivery and absorption of nutrients and therapeutics, such as CBD
(Nano- and Microscale Drug Delivery Systems, 2017).”
To view the full press release, visit http://ibn.fm/dZXum
About Pressure BioSciences Inc.
Pressure BioSciences, Inc. is a leader in the development
and sale of innovative, broadly enabling, pressure-based solutions for the
worldwide life sciences industry. The company’s products are based on the
unique properties of both constant (i.e., static) and alternating (i.e.,
pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented
enabling technology platform that uses alternating cycles of hydrostatic
pressure between ambient and ultra-high levels to safely and reproducibly
control bio-molecular interactions (e.g., cell lysis, biomolecule extraction).
PBIO’s primary focus is in the development of PCT-based products for biomarker
and target discovery, drug design and development, biotherapeutics
characterization and quality control, soil & plant biology, forensics, and
counter-bioterror applications. Additionally, major new market opportunities
have emerged in the use of its pressure-based technologies in the following
areas: (1) the use of its recently acquired PreEMT technology from BaroFold, Inc.
to allow entry into the biologics contract research services sector, and (2)
the use of its recently-patented, scalable, high-efficiency, pressure-based
Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of
otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher
quality, homogenized, extended shelf-life or room temperature stable low-acid
liquid foods that cannot be effectively preserved using existing non-thermal
technologies. For more information, visit the company’s website at www.PressureBiosciences.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
